Absorption, distribution, metabolism, and excretion of [
3-n-butylphthalide (NBP)
Mass balance
Metabolism
Pharmacokinetics
Tissue distribution
[(14)C]NBP
Journal
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
ISSN: 1873-376X
Titre abrégé: J Chromatogr B Analyt Technol Biomed Life Sci
Pays: Netherlands
ID NLM: 101139554
Informations de publication
Date de publication:
01 Sep 2021
01 Sep 2021
Historique:
received:
08
07
2021
revised:
19
08
2021
accepted:
25
08
2021
pubmed:
10
9
2021
medline:
27
1
2022
entrez:
9
9
2021
Statut:
ppublish
Résumé
3-n-Butylphthalide (NBP) has a considerable neuroprotective effect and is currently used for the treatment of ischemic stroke. NBP was launched on the market in 2004. However, information on its metabolism in humans and preclinical animal models is insufficient. Although the metabolism of unradiolabeled NBP in humans has been reported, the quantitative metabolite profile, blood-to-plasma radioactivity concentration ratio (B/P), and tissue distribution of this drug remain unclear. We evaluated the pharmacokinetics, tissue distribution, mass balance, and metabolism of NBP in rats after a single oral dose of 60 mg/kg (100 μCi/kg) [
Identifiants
pubmed: 34500404
pii: S1570-0232(21)00396-2
doi: 10.1016/j.jchromb.2021.122915
pii:
doi:
Substances chimiques
Benzofurans
0
Carbon Radioisotopes
0
3-n-butylphthalide
822Q956KGM
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
122915Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.